Author:
Alanzazi Nawaf,AlMukhaylid Sarah,Iqbal Zafar
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference61 articles.
1. Comparative efficacy and safety of different doses of ponatinib versus other tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia: a systematic review and network meta-analysis;S Zhang;Expert Opin Drug Saf,2023
2. Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosis;A Wu;Leukemia,2023
3. Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance;R Yoshimaru;Int J Mol Sci,2023
4. Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate;Siti Mariam;Front Oncol,2022
5. Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia;M Annunziata;Front Oncol,2020